World's Best Scientists 2026 revealed!
Ruud Delwel

Ruud Delwel

D-Index & Metrics

Medicine

D-Index
73
Citations
24890
World Ranking
19563
National Ranking
713

Ruud Delwel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ruud Delwel sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 328 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ruud Delwel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ruud Delwel sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 73 D-Index — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ruud Delwel is affiliated with Erasmus MC in the Netherlands and has an extensive publication record primarily focused on acute myeloid leukemia (AML) and related fields. The scientist has contributed to 44 publications in the domains of Biochemistry, Genetics, and Molecular Biology, as well as 29 publications in Medicine. Their research spans several subfields including Molecular Biology, Hematology, Genetics, Oncology, and Immunology.

The main topics explored by Ruud Delwel include:

  • Acute Myeloid Leukemia Research
  • Protein Degradation and Inhibitors
  • Genomics and Chromatin Dynamics
  • Epigenetics and DNA Methylation
  • Histone Deacetylase Inhibitors Research
  • RNA modifications and cancer
  • RNA Research and Splicing

Frequent publication venues for Delwel's work encompass key journals in hematology and oncology such as Blood, with 11 publications, and others including HemaSphere (3 publications), Cancer Discovery (2 publications), Haematologica (2 publications), and Nature Communications (1 publication).

Selected recent papers authored by or involving Ruud Delwel include:

  • The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops, 2021, Nature Communications
  • Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia, 2020, Blood
  • Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML, 2020, Cancer Discovery
  • BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells, 2020, Blood
  • Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia, 2021, Cancer Discovery

Ruud Delwel has collaborated frequently with several co-authors, including:

  • Roger Mulet-Lazaro (15 collaborations)
  • Marije Havermans (10 collaborations)
  • Leonie Smeenk (9 collaborations)
  • Stanley van Herk (8 collaborations)
  • Eric M. Bindels (7 collaborations)

Best Publications

  • Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

    Maria E. Figueroa;Omar Abdel-Wahab;Chao Lu;Patrick S. Ward

  • Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

    Mark A. Dawson;Rab K. Prinjha;Antje Dittmann;George Giotopoulos

  • Prognostically useful gene-expression profiles in acute myeloid leukemia.

    Peter J.M. Valk;Roel G.W. Verhaak;M. Antoinette Beijen;Claudia A.J. Erpelinck

  • DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

    Maria E. Figueroa;Sanne Lugthart;Yushan Li;Claudia Erpelinck-Verschueren

  • Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): Association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance

    Roel G. W. Verhaak;Chantal S. Goudswaard;Wim van Putten;Maarten A. Bijl

  • Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

    Bas J. Wouters;Bob Löwenberg;Claudia A. J. Erpelinck-Verschueren;Wim L. J. van Putten

  • A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia

    Stefan Gröschel;Stefan Gröschel;Mathijs A Sanders;Remco Hoogenboezem;Elzo de Wit

  • Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity

    Erdogan Taskesen;Lars Bullinger;Andrea Corbacioglu;Mathijs A. Sanders

  • Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling

    Roel G.W. Verhaak;Bas J. Wouters;Claudia A.J. Erpelinck;Saman Abbas

  • Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia

    Sheng Li;Francine E Garrett-Bakelman;Stephen S Chung;Mathijs A Sanders

  • The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation

    Su Jung Song;Keisuke Ito;Ugo Ala;Lev Kats

  • High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients.

    Sahar Barjesteh van Waalwijk van Doorn-Khosrovani;Claudia Erpelinck;Wim L. J. van Putten;Peter J. M. Valk

  • Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML.

    Barjesteh van Waalwijk van Doorn-Khosrovani S;Erpelinck C;Meijer J;van Oosterhoud S

  • High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated.

    Sanne Lugthart;Ellen van Drunen;Yvette van Norden;Antoinette van Hoven

  • Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia

    Ana Flávia Tibúrcio Ribeiro;Ana Flávia Tibúrcio Ribeiro;Marta Pratcorona;Marta Pratcorona;Claudia Erpelinck-Verschueren;Veronika Rockova

  • Mutations in N-ras predominate in acute myeloid leukemia

    J. L. Bos;M. Verlaan-De Vries;A. J. Van Der Eb;J. W. G. Janssen

  • Base-Pair Resolution DNA Methylation Sequencing Reveals Profoundly Divergent Epigenetic Landscapes in Acute Myeloid Leukemia

    Altuna Akalin;Francine E. Garrett-Bakelman;Matthias Kormaksson;Jennifer Busuttil

  • High EVI1 Expression Predicts Outcome in Younger Adult Patients With Acute Myeloid Leukemia and Is Associated With Distinct Cytogenetic Abnormalities

    Stefan Gröschel;Sanne Lugthart;Richard F. Schlenk;Peter J.M. Valk

  • Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.

    Bas J. Wouters;Ruud Delwel

  • Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid Leukemia

    Sanne Lugthart;Stefan Gröschel;H. Berna Beverloo;Sabine Kayser

Frequent Co-Authors

Peter J. M. Valk
Peter J. M. Valk Erasmus University Rotterdam
Bob Löwenberg
Bob Löwenberg Erasmus MC
Daniel G. Tenen
Daniel G. Tenen National University of Singapore
Ivo P. Touw
Ivo P. Touw Erasmus University Rotterdam
Ari Melnick
Ari Melnick Cornell University
Konstanze Döhner
Konstanze Döhner University of Ulm
Maria E. Figueroa
Maria E. Figueroa University of Miami
Hartmut Döhner
Hartmut Döhner University of Ulm
Lars Bullinger
Lars Bullinger Charité - University Medicine Berlin
H. Berna Beverloo
H. Berna Beverloo Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The field of medicine in the USA is diverse, offering various educational and career opportunities beyond the traditional MD track. For those interested in advanced nursing, cheapest online dnp programs allow registered nurses to earn a Doctor of Nursing Practice degree at an affordable rate, enhancing leadership and clinical skills.

Pharmacists are also in high demand, and you can now pursue an online pharmacist degree from accredited institutions, making this career path accessible and flexible for working professionals.

If you’re interested in the intersection between healthcare and information technology, earning an him bachelor's degree online prepares you for managing health data, ensuring privacy, and supporting efficient healthcare administration.

For those seeking quick entry into the workforce, affordable medical billing and coding programs offer fast, budget-friendly training for essential administrative roles in hospitals and clinics.

Exploring these related online degrees and career pathways can open doors in medicine and allied health fields—making healthcare education more accessible than ever.

Best Scientists Citing Ruud Delwel

Trending Scientists

Recently Published Articles